> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Hospira Sodium Bicarbonate Recall
- URL: https://www.fdaweb.com/hospira-sodium-bicarbonate-recall/
- Published: 2024-01-02T12:00:00.000Z
- Updated: 2026-09-14T14:19:01.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5156048

FDA says Hospira has recalled one lot each of its 4.2% sodium bicarbonate injection, 8.4% sodium bicarbonate injection, and atropine sulfate injection due to the potential presence of glass particulate matter. An agency [notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-inc-issues-voluntary-nationwide-recall-42-sodium-bicarbonate-injection-84-sodium-bicarbonate?ref=fdaweb.com) says the potential for glass particulate matter was identified during product inspection. Hospira says that to 12/21/2023 it had not received reports of any adverse events associated with the issue for the recalled lots.